ANO1 and breast carcinoma: Different labs found that TMEM16A promoted proliferation in a variety of cancer cell lines, such as HNSCC(CAL33), breast cancer (MCF10A), pancreatic cancer (CFPAC-1), and prostate cancer (PC-3) [32].